狂犬病诊断市场 - 2018-2028 年全球产业规模、份额、趋势、机会与预测，按诊断方法、技术方法、地区、竞争细分

2022 年，全球狂犬病诊断市场价值为 19.6 亿美元，预计在预测期内将强劲增长，到 2028 年复合CAGR为7.64%。狂犬病是一种病毒性疾病，可透过任何动物咬伤（尤其是狗）传播。它与神经系统有关，主要由弹状病毒引起。常见症状包括发烧和接触部位刺痛。这些症状之后还会出现一些其他症状，例如剧烈运动、无法控制的兴奋、怕水、无法移动身体部位、意识混乱和失去意识。狂犬病通常透过直接萤光抗体（DFA）测试在动物中发现，该测试可以检测脑组织中是否有狂犬病病毒抗原。狂犬病是一种可透过疫苗预防的病毒性疾病。在受影响大脑的任何部位检测到狂犬病病毒后即可做出狂犬病诊断，但为了排除狂犬病，检测必须包括大脑至少两个部位的组织，最好是脑干和小脑。狂犬病的诊断是透过采集唾液、血液、血清、脑脊髓液和后脑勺皮肤毛囊样本进行的。可以透过病毒分离或逆转录，然后进行聚合酶炼式反应 (RT-PCR) 来测试唾液。可以检测血液、血清和脑脊髓液中是否有狂犬病病毒抗体。

主要市场驱动因素

狂犬病发生率增加

市场概况
预测期	2024-2028
2022 年市场规模	19.6亿美元
2028 年市场规模	30.5亿美元
2023-2028 年CAGR	7.64%
成长最快的细分市场	萤光抗体测试（FAT）
最大的市场	北美洲

全球狂犬病发病率不断上升，将推动全球狂犬病诊断市场的大幅成长。随着狂犬病病例的发病率激增，对先进诊断解决方案的需求不断增加，以促进及时、准确的检测。人们对狂犬病严重性和早期诊断重要性的认识不断提高，促使个人和医疗保健专业人员采用先进的诊断工具。各国政府和医疗机构正在积极投资狂犬病控制项目，为诊断市场的扩张做出贡献。对预防措施的日益重视，加上狂犬病控制的严格规定，进一步增加了对高效诊断技术的需求。市场参与者正在透过创新和推出最先进的诊断产品来应对这一不断增长的需求。这种以技术进步和策略合作为特征的竞争格局促进了市场成长。此外，贸易和旅行的全球化增加了狂犬病传播的风险，因此需要在全球范围内建立强大的诊断基础设施。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场区隔

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要产业伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球狂犬病诊断市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依诊断方法分类（萤光抗体检测（FAT）、免疫组织化学检测、扩增方法、组织学检查、血清学检测）
  • 依技术方法（ELISA/免疫组织化学、层析技术、PCR、其他）
  • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
  • 按公司划分 (2022)
• 市场地图
  • 按诊断方法
  • 依技术方法
  • 按地区

第 6 章：北美狂犬病诊断市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依诊断方法分类（萤光抗体检测（FAT）、免疫组织化学检测、扩增方法、组织学检查、血清学检测）
  • 依技术方法（ELISA/免疫组织化学、层析技术、PCR、其他）
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲狂犬病诊断市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依诊断方法分类（萤光抗体检测（FAT）、免疫组织化学检测、扩增方法、组织学检查、血清学检测）
  • 依技术方法（ELISA/免疫组织化学、层析技术、PCR、其他）
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第 8 章：亚太地区狂犬病诊断市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依诊断方法分类（萤光抗体检测（FAT）、免疫组织化学检测、扩增方法、组织学检查、血清学检测）
  • 依技术方法（ELISA/免疫组织化学、层析技术、PCR、其他）
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲狂犬病诊断市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依诊断方法分类（萤光抗体检测（FAT）、免疫组织化学检测、扩增方法、组织学检查、血清学检测）
  • 依技术方法（ELISA/免疫组织化学、层析技术、PCR、其他）
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲狂犬病诊断市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依诊断方法分类（萤光抗体检测（FAT）、免疫组织化学检测、扩增方法、组织学检查、血清学检测）
  • 依技术方法（ELISA/免疫组织化学、层析技术、PCR、其他）
  • 按国家/地区
• MEA：国家分析
  • 南非狂犬病诊断
  • 沙乌地阿拉伯狂犬病诊断
  • 阿联酋狂犬病诊断

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球狂犬病诊断市场：SWOT 分析

第 14 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• Bio-Rad 实验室有限公司
  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials (As Reported)
  • Key Personnel
  • SWOT Analysis
• 默克公司。
• 英杰华系统生物公司。
• 创造性的诊断。
• Demeditec 诊断有限公司。
• 阿贝萨有限公司
• 诺根生物技术公司
• 生物笔记公司
• 快速生技国际公司
• MyBioSource.com。

第 16 章：策略建议

Global Rabies Diagnostics Market has valued at USD 1.96 Billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 7.64% through 2028. Rabies is a viral disease that is transmitted by any animal bite, especially a dog. It is associated with the nervous system which is mainly caused due to rhabdovirus. Common symptoms can include fever and tingling at the site of exposure. These symptoms are followed by some other symptoms such as violent movements, uncontrolled excitement, fear of water, an inability to move parts of the body, confusion, and loss of consciousness. Rabies is generally found in animals with the help of a direct fluorescent antibody (DFA) test which can detect the presence of rabies virus antigens in brain tissue. Rabies is a vaccine-preventable viral disease. A rabies diagnosis can be made after detection of rabies virus in any part of the affected brain, but to rule out rabies, the test must include tissue from at least two parts of the brain, preferably the brain stem and the cerebellum. The diagnosis of rabies is performed on samples of saliva, blood, serum, cerebrospinal fluid, and skin hair follicles from the back of the head. Saliva can be tested by virus isolation or reverse transcription followed by the polymerase chain reaction (RT-PCR). Blood, serum, and cerebrospinal fluid can be tested for the presence of antibodies against the rabies virus.

Key Market Drivers

Increasing Incidence of Rabies

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 1.96 Billion
Market Size 2028	USD 3.05 Billion
CAGR 2023-2028	7.64%
Fastest Growing Segment	Fluorescent Antibody Test (FAT)
Largest Market	North America

The escalating incidence of rabies worldwide is poised to propel substantial growth in the Global Rabies Diagnostics Market. As the prevalence of rabies cases surges, there is a heightened demand for advanced diagnostic solutions to facilitate timely and accurate detection. The rising awareness regarding the severity of rabies and the importance of early diagnosis is driving both individuals and healthcare professionals to adopt sophisticated diagnostic tools. Governments and healthcare organizations are actively investing in rabies control programs, contributing to the expansion of the diagnostics market. The increasing emphasis on preventive measures, coupled with stringent regulations for the control of rabies, further augments the need for efficient diagnostic technologies. Market players are responding to this burgeoning demand by innovating and introducing state-of-the-art diagnostic products. This competitive landscape, characterized by technological advancements and strategic collaborations, fosters market growth. Additionally, the globalization of trade and travel amplifies the risk of rabies transmission, necessitating robust diagnostic infrastructure worldwide.

Advancements in Diagnostic Technologies

The dynamic growth of the Global Rabies Diagnostics Market is intricately linked to continuous advancements in diagnostic technologies. Technological breakthroughs in the development of diagnostic tools have significantly enhanced the accuracy, speed, and efficiency of rabies detection. Innovative approaches, such as molecular diagnostics, immunohistochemistry, and serological assays, offer heightened sensitivity and specificity in identifying the rabies virus. These technological strides not only improve diagnostic precision but also contribute to the overall efficiency of rabies control programs. Automation and integration of diagnostic processes streamline workflows, reducing turnaround times and enabling prompt decision-making by healthcare professionals. Furthermore, the integration of artificial intelligence and machine learning algorithms enhances data interpretation, providing valuable insights for effective disease management. The global adoption of cutting-edge diagnostic technologies fosters a competitive landscape among industry players, driving research and development initiatives. As a result, the market witnesses a continuous influx of novel diagnostic solutions, creating a favorable environment for growth. In essence, advancements in diagnostic technologies play a pivotal role in catalyzing the expansion of the Global Rabies Diagnostics Market by elevating the standards of accuracy, efficiency, and innovation in rabies detection methodologies.

Growing Veterinary Concerns

The burgeoning veterinary concerns globally are poised to be a significant driver propelling the growth of the Global Rabies Diagnostics Market. With an increasing focus on animal health and welfare, there is a heightened awareness among pet owners, veterinarians, and regulatory bodies about the threat of rabies. The rising incidence of rabies in animals underscores the crucial need for effective diagnostic tools to ensure timely detection and containment. Veterinary clinics and animal healthcare facilities are actively seeking advanced diagnostic solutions to address the escalating concerns surrounding rabies transmission. Additionally, stringent regulations and guidelines pertaining to animal health and zoonotic diseases emphasize the importance of robust diagnostic measures, further fueling the demand for cutting-edge technologies in the field. The growing trend of pet ownership, coupled with an upsurge in commercial livestock farming, amplifies the risk of rabies transmission, necessitating comprehensive diagnostic strategies. Consequently, the Global Rabies Diagnostics Market is witnessing increased traction as veterinary professionals and pet owners alike recognize the pivotal role of diagnostics in safeguarding animal populations. This heightened awareness and concern for veterinary health contribute significantly to the market's expansion, creating opportunities for innovative diagnostic solutions and fostering industry growth.

Key Market Challenges

Limited Access to Diagnostics in Developing Regions

The growth of the Global Rabies Diagnostics Market faces a notable hurdle in the form of limited access to diagnostics in developing regions. Insufficient infrastructure, economic constraints, and inadequate healthcare resources in these areas contribute to a significant gap in diagnostic capabilities. The lack of accessible and affordable diagnostic tools for rabies in these regions hampers timely detection and intervention. In developing economies, where rabies poses a considerable public health risk, the scarcity of diagnostic facilities exacerbates the challenges of disease control. Limited awareness and education about the importance of early detection further compound this issue. The absence of a robust diagnostic infrastructure not only delays the identification of rabies cases but also impedes the implementation of effective preventive measures. This accessibility gap creates a stark disparity in the global fight against rabies, hindering the market's growth potential. Addressing this challenge necessitates collaborative efforts between governments, non-profit organizations, and industry players to invest in and expand diagnostic capabilities in developing regions. Bridging this gap not only serves public health interests but also unlocks untapped market opportunities for innovative and affordable rabies diagnostic solutions tailored to the unique challenges of these regions.

Vaccine Accessibility and Affordability

The accessibility and affordability of rabies vaccines present a potential hindrance to the growth of the Global Rabies Diagnostics Market. While effective vaccines are critical for rabies prevention, their widespread availability and affordability could reduce the perceived urgency for investing in diagnostic technologies. In regions where access to vaccines is limited, there may be a tendency to prioritize vaccination campaigns over diagnostic infrastructure, diverting attention and resources from the diagnostic market. Furthermore, if vaccines become more accessible and affordable, there might be a decreased emphasis on the early detection of rabies through diagnostic tools. The perception that vaccination alone is a sufficient preventive measure could overshadow the importance of diagnostics in identifying and managing rabies cases, potentially slowing market growth. To mitigate this challenge, stakeholders in the rabies diagnostics market need to emphasize the complementary role of diagnostics in disease surveillance, even in the presence of effective vaccines. Education campaigns highlighting the significance of early detection for effective rabies control can help reshape the narrative, ensuring that both diagnostics and vaccines are recognized as integral components of a comprehensive rabies prevention strategy.

Key Market Trends

Adoption of Point-of-Care (POC) Diagnostics

The adoption of Point-of-Care (POC) diagnostics is poised to drive substantial growth in the Global Rabies Diagnostics Market. POC diagnostics offer real-time, on-site testing, eliminating the need for complex laboratory infrastructure and expediting the diagnosis of rabies. This shift towards decentralized testing is particularly advantageous in remote or underserved areas where access to traditional diagnostic facilities is limited. The portability and rapid results provided by POC diagnostics enhance the efficiency of rabies detection, enabling prompt decision-making by healthcare professionals. This immediacy is crucial in managing and controlling the spread of rabies, as early detection is pivotal for effective intervention. Moreover, the simplicity of POC diagnostic devices facilitates their use by a broader range of healthcare providers, including field veterinarians and community health workers. As a result, the adoption of POC diagnostics aligns with global efforts to enhance the accessibility of rabies testing, especially in regions with limited healthcare infrastructure.

The market's response to this paradigm shift is evident through increased investments in the development and commercialization of user-friendly, rapid POC diagnostic solutions. In conclusion, the growing adoption of Point-of-Care diagnostics emerges as a key driver propelling the expansion of the Global Rabies Diagnostics Market, addressing the demand for timely and accessible rabies testing solutions.

Digitalization and Data Analytics

The growth trajectory of the Global Rabies Diagnostics Market is set to be significantly influenced by the integration of digitalization and data analytics. Digital technologies are revolutionizing diagnostic processes by enabling seamless data capture, analysis, and interpretation. In the context of rabies diagnostics, the application of digital tools enhances the efficiency of result reporting, ensuring faster and more accurate communication of test outcomes. Moreover, data analytics plays a pivotal role in deriving meaningful insights from diagnostic information, aiding in the identification of patterns and trends associated with rabies prevalence. Advanced analytics platforms contribute to predictive modeling, enabling better forecasting of disease spread and facilitating proactive measures for containment. The use of digital platforms also facilitates remote monitoring and real-time collaboration among healthcare professionals, veterinarians, and epidemiologists, fostering a more coordinated approach to rabies control. Additionally, the digitization of diagnostic data contributes to robust disease surveillance systems, enhancing the overall effectiveness of public health initiatives. In response to this digital transformation, the market is witnessing increased investments in digital diagnostic solutions. As the synergy between digitalization and data analytics continues to evolve, it is expected to be a key driver propelling the growth of the Global Rabies Diagnostics Market, promoting efficiency, accuracy, and informed decision-making in the fight against rabies.

Segmental Insights

Diagnostic Method Insights

Based on the Diagnostic Method, the Fluorescent Antibody Test (FAT) segment is anticipated to witness substantial market growth throughout the forecast period. The Fluorescent Antibody Test (FAT) diagnostic method is poised to be a significant driver of growth in the Global Rabies Diagnostics Market. FAT, renowned for its high sensitivity and specificity, is a pivotal tool in the accurate detection of the rabies virus. This diagnostic method utilizes fluorescently labeled antibodies to specifically bind to rabies antigens, allowing for visual confirmation under a fluorescent microscope. The reliability and precision offered by FAT make it a preferred choice for many healthcare professionals and veterinary practitioners in confirming rabies cases. Its ability to provide rapid results enhances the efficiency of diagnostic workflows, facilitating timely interventions and control measures. Furthermore, as the global emphasis on rabies prevention and control intensifies, the demand for robust diagnostic methods like FAT is on the rise. The method's effectiveness in identifying the virus in various animal species contributes to its widespread adoption. The growth of the Global Rabies Diagnostics Market is thus intricately linked to the increasing recognition and utilization of the Fluorescent Antibody Test, with its superior diagnostic capabilities playing a pivotal role in advancing the precision and reliability of rabies detection methodologies.

Technology Method Insights

Based on the Technology Method segment, the Cardiovascular segment has been the dominant force in the market. The growth of the Global Rabies Diagnostics Market is poised to be significantly propelled by the adoption of ELISA (Enzyme-Linked Immunosorbent Assay) and Immunohistochemistry methods. These sophisticated diagnostic techniques play a pivotal role in accurately detecting the rabies virus and have become integral components of modern diagnostic workflows. ELISA, known for its high sensitivity and specificity, allows for the quantification of rabies-specific antibodies or antigens, providing reliable results in a cost-effective and time-efficient manner. Its versatility and adaptability make it a preferred choice in large-scale diagnostic settings, contributing to the scalability of rabies testing programs. Immunohistochemistry, on the other hand, enables the visualization of rabies antigens in tissue samples, offering valuable insights into the distribution and localization of the virus. This method enhances diagnostic precision and aids in understanding the pathology of rabies, guiding appropriate treatment and control measures. The increasing demand for accurate and efficient rabies diagnostics, driven by heightened global awareness and regulatory efforts, positions ELISA and Immunohistochemistry as key drivers of market growth. As healthcare systems worldwide prioritize advanced diagnostic solutions, the adoption of these methods is expected to play a pivotal role in advancing the capabilities of the Global Rabies Diagnostics Market.

Regional Insights

North America, specifically the Rabies Diagnostics Market, dominated the market in 2022, primarily due to North America is poised to be a significant driver of growth in the Global Rabies Diagnostics Market. The region's contribution is propelled by several factors, including a robust healthcare infrastructure, advanced diagnostic technologies, and heightened awareness of zoonotic diseases. The stringent regulatory environment and proactive measures in public health further stimulate the demand for cutting-edge rabies diagnostic solutions.

The prevalence of rabies cases in wildlife and domestic animals, combined with the region's commitment to effective disease control, elevate the need for accurate and timely diagnostics. Additionally, the strategic initiatives undertaken by government bodies and healthcare organizations in North America to curb the spread of rabies underscore the market's growth potential. Moreover, the presence of key market players and continuous investments in research and development activities contribute to the innovation and commercialization of advanced diagnostic tools. As North America prioritizes preventive healthcare measures, the Global Rabies Diagnostics Market is positioned to benefit significantly from the region's progressive approach, making it a pivotal driver in the overall expansion of the market.

Key Market Players

Bio-Rad Laboratories, Inc

Merck KGaA.

Aviva Systems Biology Corporation.

Creative Diagnostics.

Demeditec Diagnostics GmbH.

Abbexa Ltd.

Norgen Biotek Corp.

BioNote, Inc.

Express Biotech International Inc.

Report Scope:

In this report, the Global Rabies Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Rabies Diagnostics Market, By Diagnostic Method:

• Fluorescent Antibody Test (FAT)
• Immunohistochemical Test
• Amplification Methods
• Histologic Examination
• Serology Tests

Rabies Diagnostics Market, By Technology Method:

• ELISA/Immunohistochemistry
• Chromatography Techniques
• PCR
• Others

Rabies Diagnostics Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Rabies Diagnostics Market.

Available Customizations:

• Global Rabies Diagnostics market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Rabies Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Diagnostic Method (Fluorescent Antibody Test (FAT), Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests)
  • 5.2.2. By Technology Method (ELISA/Immunohistochemistry, Chromatography Techniques, PCR, Others)
  • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.4. By Company (2022)
• 5.3. Market Map
  • 5.3.1 By Diagnostic Method
  • 5.3.2 By Technology Method
  • 5.3.3 By Region

6. North America Rabies Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Diagnostic Method (Fluorescent Antibody Test (FAT), Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests)
  • 6.2.2. By Technology Method (ELISA/Immunohistochemistry, Chromatography Techniques, PCR, Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Rabies Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Diagnostic Method
      • 6.3.1.2.2. By Technology Method
  • 6.3.2. Canada Rabies Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Diagnostic Method
      • 6.3.2.2.2. By Technology Method
  • 6.3.3. Mexico Rabies Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Diagnostic Method
      • 6.3.3.2.2. By Technology Method

7. Europe Rabies Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Diagnostic Method (Fluorescent Antibody Test (FAT), Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests)
  • 7.2.2. By Technology Method (ELISA/Immunohistochemistry, Chromatography Techniques, PCR, Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Rabies Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Diagnostic Method
      • 7.3.1.2.2. By Technology Method
  • 7.3.2. Germany Rabies Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Diagnostic Method
      • 7.3.2.2.2. By Technology Method
  • 7.3.3. United Kingdom Rabies Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Diagnostic Method
      • 7.3.3.2.2. By Technology Method
  • 7.3.4. Italy Rabies Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Diagnostic Method
      • 7.3.4.2.2. By Technology Method
  • 7.3.5. Spain Rabies Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Diagnostic Method
      • 7.3.5.2.2. By Technology Method

8. Asia-Pacific Rabies Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Diagnostic Method (Fluorescent Antibody Test (FAT), Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests)
  • 8.2.2. By Technology Method (ELISA/Immunohistochemistry, Chromatography Techniques, PCR, Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Rabies Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Diagnostic Method
      • 8.3.1.2.2. By Technology Method
  • 8.3.2. India Rabies Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Diagnostic Method
      • 8.3.2.2.2. By Technology Method
  • 8.3.3. Japan Rabies Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Diagnostic Method
      • 8.3.3.2.2. By Technology Method
  • 8.3.4. South Korea Rabies Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Diagnostic Method
      • 8.3.4.2.2. By Technology Method
  • 8.3.5. Australia Rabies Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Diagnostic Method
      • 8.3.5.2.2. By Technology Method

9. South America Rabies Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Diagnostic Method (Fluorescent Antibody Test (FAT), Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests)
  • 9.2.2. By Technology Method (ELISA/Immunohistochemistry, Chromatography Techniques, PCR, Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Rabies Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Diagnostic Method
      • 9.3.1.2.2. By Technology Method
  • 9.3.2. Argentina Rabies Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Diagnostic Method
      • 9.3.2.2.2. By Technology Method
  • 9.3.3. Colombia Rabies Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Diagnostic Method
      • 9.3.3.2.2. By Technology Method

10. Middle East and Africa Rabies Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Diagnostic Method (Fluorescent Antibody Test (FAT), Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests)
  • 10.2.2. By Technology Method (ELISA/Immunohistochemistry, Chromatography Techniques, PCR, Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Rabies Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Diagnostic Method
      • 10.3.1.2.2. By Technology Method
  • 10.3.2. Saudi Arabia Rabies Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Diagnostic Method
      • 10.3.2.2.2. By Technology Method
  • 10.3.3. UAE Rabies Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Diagnostic Method
      • 10.3.3.2.2. By Technology Method

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Rabies Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Bio-Rad Laboratories, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Product Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Key Personnel
  • 15.1.6. SWOT Analysis
• 15.2. Merck KGaA.
• 15.3. Aviva Systems Biology Corporation.
• 15.4. Creative Diagnostics.
• 15.5. Demeditec Diagnostics GmbH.
• 15.6. Abbexa Ltd.
• 15.7. Norgen Biotek Corp.
• 15.8. BioNote, Inc.
• 15.9. Express Biotech International Inc.
• 15.10. MyBioSource.com.

16. Strategic Recommendations